GeneQuantum Healthcare (Suzhou) Co., Ltd.
GeneQuantum Healthcare (Suzhou) Co., Ltd.
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| GQ1001 Combined With Pyrotinib for Treatment With HER2 Positive Metastatic Breast Cancer | Advanced/ Metastatic Her-2 Positive Breast Cancer | Recruiting | Phase 1 / Phase 2 | 2026-07-24 | NCT05575804 | |
| A Trial Comparing GQ1005 and T-DM1 in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer | HER2-positive Breast Cancer | Recruiting | Phase 3 | 2026-06-29 | NCT07673029 | |
| A Study of GQ1010 in Subjects With Advanced Solid Tumors | Advanced Malignant Solid Tumors | Recruiting | Phase 1 / Phase 2 | 2025-02-10 | NCT06464055 |